ArticleTransplantation and cellular therapy2021

Myeloablative Busulfan/Melphalan Consolidation following Induction Chemotherapy for Patients with Newly Diagnosed High-Risk Neuroblastoma: Children's Oncology Group Trial ANBL12P1.

M Meaghan Granger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.